Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-283110·Bain Capital Life Sciences Fund, L.P.
Schedule 13G ownership disclosure
PHARVARIS N V
Ordinary Shares, Euro 0.12 par value per share · CUSIP: N69605108
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bain Capital Life Sciences Fund, L.P.
Shares: 1,867,629 · Class: 3.0%
- BCIP Life Sciences Associates, LP
Shares: 191,165 · Class: 0.3%
- Bain Capital Life Sciences Opportunities III, LP
Shares: 1,122,481 · Class: 1.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-283110
- Form type
- SCHEDULE 13G/A
- Filer
- Bain Capital Life Sciences Fund, L.P.
- CIK
- CIK 1687968
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership